Christopher Parker
Plus aucun poste en cours
Fortune : 23 940 $ au 31/05/2024
Profil
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd.
from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd.
from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANTEOTECH LTD
0,06% | 27/06/2023 | 1 500 000 ( 0,06% ) | 23 940 $ | 31/05/2024 |
Anciens postes connus de Christopher Parker
| Sociétés | Poste | Fin |
|---|---|---|
| ANTEOTECH LIMITED | Directeur Général | 01/12/2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Corporate Officer/Principal | 01/07/2017 |
Formation de Christopher Parker
| Queensland University of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANTEOTECH LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Health Technology |
